These findings collectively suggest that the ubiquitin ligase CBL-b exerts an inhibitory effect on tumor growth in multidrug-resistant gastric cancer cells through the ubiquitination and degradation of IGF-1R (Barrueco et al., 1989; Xu et al., 2013; CHe et al., 2017). The gene discussed is CBLB; the disease is neoplasm.